Onkos Surgical
77 East Halsey Road
Parsipanny
New Jersey
07054
United States
Website: http://www.onkossurgical.com/
29 articles about Onkos Surgical
-
Onkos Surgical Presents at the Canaccord Genuity 2024 Musculoskeletal Healthcare Conference
2/13/2024
Onkos Surgical presented Monday, February 12th at the Canaccord Genuity Musculoskeletal Conference in San Francisco.
-
Onkos Surgical to Present at Canaccord Genuity's 2024 Musculoskeletal Conference
2/5/2024
Onkos Surgical, Inc. announced today that it will present at Canaccord Genuity's 2024 Musculoskeletal Conference in San Francisco, CA. Patrick Treacy, Onkos CEO and co-founder, is scheduled to present a corporate overview and update on February 12th, at the Westin St. Francis at 11:00 a.m. PST.
-
Onkos Surgical Announces Expanded Capability in Pediatric Musculoskeletal Oncology and Unveils New Manufacturing and Innovation Center
7/19/2023
Onkos Surgical announced its launch of the JTS Extendible Prosthesis, a novel growing implant designed for pediatric patients with bone cancer, and unveiled its new, state-of-the-art manufacturing and R&D innovation center at its Parsippany, NJ headquarters to support the integration and growth of the technology.
-
Onkos Surgical Receives FDA 510(k) Clearance for 3D Printed, Patient-Specific Pelvic Reconstruction System
7/14/2022
Onkos Surgical today announced that it has received 510(k) clearance for its My3D® Personalized Pelvic Reconstruction system.
-
Onkos Surgical Announces Definitive Agreement to Acquire the JTS Extendible Prosthesis
6/13/2022
Company expands musculoskeletal oncology portfolio with device to treat pediatric bone cancer.
-
Onkos Surgical Announces Market Leading Growth and Strategy at Premier MedTech Investor Conferences
3/23/2022
Onkos Surgical presented its plans for accelerated commercial growth and further expansion of its product offerings at two premier MedTech investor meetings that precede the 2022 American Academy of Orthopedic Surgeons annual meeting.
-
Money on the Move: September 1 – 7
9/8/2021
Life sciences funding rounds were quieter this week with the Labor Day holiday. Here’s the short list. -
Onkos Surgical Raises $15 Million in Series C Funding
9/1/2021
Onkos Surgical, a leading innovator of solutions for musculoskeletal oncology and complex orthopaedic procedures, announced that it has raised $15 million in Series C funding from its existing investor syndicate.
-
Onkos Surgical Announces FDA 510(k) Clearance of its BioGrip® Modular Porous Collars, a First-of-Its-Kind Solution to Help Address Implant Loosening in Orthopaedic Oncology and Complex Revision Surgery
6/22/2021
Onkos Surgical today announced that it has received FDA 510(k) clearance for its modular collar portfolio featuring the Company's BioGrip® 3D-printed implant technology.
-
Onkos Surgical® Celebrates Patient Experience Week with Focus on Patient-Centered Innovation
4/29/2021
Highlights innovations for precision musculoskeletal oncology and complex orthopaedic procedures; sees growing industry adoption
-
Onkos Surgical® continues its innovation in musculoskeletal oncology and complex orthopaedic reconstruction with the launch of the ELEOS™ Proximal Tibia with BioGrip™ technology
12/21/2020
Onkos Surgical, Inc., an innovator in the field of musculoskeletal oncology and personalized orthopaedics, continues to deliver on its promise of commercializing innovative solutions with the launch of the new ELEOS Proximal Tibia with BioGrip technology.
-
Onkos Surgical® announces the launch of GenVie™, a novel Magnesium Bone Scaffolding technology
2/6/2020
Onkos Surgical® is pleased to announce the launch of GenVie™ Magnesium Bone Scaffold, a novel biologic technology that further expands Onkos' reach in complex limb salvage procedures.
-
Onkos Surgical® partners with Integrum® to expand US market for the OPRA™ Implant System; a revolutionary osseointegration and bone-anchored prosthetic technology
1/21/2020
Onkos Surgical, Inc. a leader in the field of musculoskeletal oncology and personalized orthopaedics announced today a multi-year agreement with Integrum AB (INTEG B: Nasdaq First North exchange).
-
Onkos Surgical® and The Sarcoma Foundation of America to Sponsor Upcoming Cancer Awareness Fundraiser
7/15/2019
Onkos Surgical, Inc. and The Sarcoma Foundation of America (SFA) are pleased to announce the "Strike Out Sarcoma" fundraiser, in honor of Sarcoma Awareness Month.
-
Karolinska Development's portfolio company Promimic announces partnership with Onkos Surgical
3/15/2019
Karolinska Development's portfolio company Promimic announces a new partnership with the U.S company Onkos Surgical® to commercialize Promimic's proprietary Hydroxyapatite Surface Technologies in Limb Salvage Surgery.
-
Onkos Surgical® Announces Partnership with Promimic AB for Development of Hydroxyapatite Surface Technology in Limb Salvage Surgery
3/14/2019
Onkos Surgical, Inc. announced today that it has partnered with Promimic AB, the world's leading innovator in nano surface modification, to commercialize Promimic's proprietary Hydroxyapatite (HA) Surface Technologies in Limb Salvage Surgery.
-
Onkos Surgical® Set to Deliver on Promise of Innovation with 7 New Products Scheduled to Launch in 2019
3/12/2019
Since its inception in October 2015, the company has already supported over 200 surgeons and over 1,100 limbs have been saved using Onkos products.
-
Onkos Surgical® Announces the Release of MyTray™ a Breakthrough in Personalized Surgical Planning
2/7/2019
Onkos Surgical, Inc. announced today that it has launched MyTray, a fully integrated personal surgical planning solution that leverages preoperative imaging and the precision of surgeon specific procedural requirements;
-
Onkos Surgical® and Insight Medical Systems team up to explore applications of augmented reality in musculoskeletal oncology
7/9/2018
Insight Medical Systems has teamed up with Onkos Surgical, Inc. to explore opportunities to apply Insight Medical’s ARVIS™
-
Onkos Surgical® Announces Major Milestone with First Patient Entered in the Surgical Oncology Research Team (SORT™) Registry
3/8/2018
The SORT Registry, sponsored by Onkos Surgical, is the first of its kind, multicenter, platform designed to prospectively collect functional, psychosocial and oncological outcomes.